An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and Pediatrics
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05040178 |
|
Recruitment Status :
Recruiting
First Posted : September 10, 2021
Last Update Posted : January 30, 2024
|
Sponsor:
Recordati Rare Diseases
Collaborator:
Target PharmaSolutions, Inc.
Information provided by (Responsible Party):
Recordati Rare Diseases
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | June 30, 2032 |
| Estimated Study Completion Date : | June 30, 2032 |